USE OF RECOMBINANT FACTOR VIIA FOR REFRACTORY BLEEDING IN VENTRICULAR ASSIST DEVICE PATIENTS: THE EDMONTON EXPERIENCE

被引：0
|
作者：
Nunes, A. J.
Hruczkowski, J.
Nahirniak, S.
MacArthur, R. G.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2012年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2012.07.627
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S363 / S364
页数：2
相关论文
共 50 条
  • [41] Experience with the use of recombinant factor VIIa in a university hospital.
    Escobar, M
    Harvey, RD
    BLOOD, 2001, 98 (11) : 70B - 70B
  • [42] Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard–Soulier syndrome
    Margareth Castro Ozelo
    Pavel Svirin
    Lubov Larina
    Annals of Hematology, 2005, 84 : 816 - 822
  • [43] Treatment of traumatic bleeding with recombinant factor VIIa
    Kenet, G
    Walden, R
    Eldad, A
    Martinowitz, U
    LANCET, 1999, 354 (9193): : 1879 - 1879
  • [44] Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding
    Dutton, Richard
    Hauser, Carl
    Boffard, Kenneth
    Dimsitts, Jeannett
    Bernard, Gordon
    Holcomb, John
    Leppaeniemi, Ari
    Tortella, Bartholemew
    Bouillon, Bertil
    CLINICAL TRIALS, 2009, 6 (05) : 467 - 479
  • [45] Recombinant factor VIIa in severe uremic bleeding
    Révész, T
    Arets, B
    Bierings, M
    van den Bos, C
    Duval, E
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 353 - 353
  • [46] OUR EXPERIENCE IN THE USE OF RECOMBINANT FACTOR VIIA (RFVIIA) IN UNSELECTED PATIENTS WITH UNCONTROLLED HAEMORRHAGE
    Lokar, L.
    Urlep-Salinovic, V
    Bizjak, B.
    Majcen, Vivod B.
    Maracic, I
    Kavas, E.
    VOX SANGUINIS, 2010, 99 : 438 - 438
  • [47] Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients
    Tobias, JD
    Groeper, K
    Berkenbosch, JF
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (01) : 12 - 16
  • [48] Uncontrolled Bleeding in Surgical Patients: The Role of Recombinant Activated Factor VIIa
    Phillips, L. E.
    Zatta, A. J.
    Schembri, N. L.
    Noone, A. K.
    Isbister, J.
    CURRENT DRUG TARGETS, 2009, 10 (08) : 744 - 770
  • [49] Use of Recombinant Factor VIIa in Critically Ill Patients
    Perreault, Marc M.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2006, 59 : 45 - 46
  • [50] Recombinant activated factor VIIa in patients at the high risk of bleeding.
    Kubisz, P
    Plamenova, I
    Chudej, J
    Stasko, J
    Hulikova, M
    BLOOD, 2003, 102 (11) : 103B - 103B
12345